USE OF MEGALIN IN URINE AS MARKER FOR DETECTING RENAL DISORDER
    1.
    发明申请
    USE OF MEGALIN IN URINE AS MARKER FOR DETECTING RENAL DISORDER 有权
    使用马替林作为标记用于检测肾功能异常

    公开(公告)号:US20120058489A1

    公开(公告)日:2012-03-08

    申请号:US13266397

    申请日:2010-04-27

    IPC分类号: G01N33/566 G01N21/76

    CPC分类号: G01N33/6872 G01N2800/347

    摘要: This invention provides a simple means for detecting a renal disorder, a diagnostic marker for a renal disorder that enables prognostic prediction of a renal disorder (e.g., diabetic nephropathy and IgA nephropathy) and evaluation of the degree of nephropathy at the phase of stage-II diabetic nephropathy by measuring the megalin level in urine associated with a renal disorder used for the detection means, and use of such marker. The invention also provides the use of human megalin obtained from the urine sample of a subject as a marker for detecting a renal disorder.

    摘要翻译: 本发明提供了一种用于检测肾脏疾病的简单方法,一种能够预测肾病(例如,糖尿病性肾病和IgA肾病)的肾病的诊断标志物,并评估II期阶段的肾病程度 通过测量与用于检测手段的肾脏疾病相关的尿液中的巨蛋白水平,以及使用这种标记物,糖尿病性肾病。 本发明还提供了从受试者的尿样获得的人巨蛋白作为检测肾病的标记物的用途。